Skip to Content

1427 5 (Farxiga 5 mg)

Generic Name: dapagliflozin

Pill with imprint 1427 5 is Yellow, Round and has been identified as Farxiga 5 mg. It is supplied by Bristol-Myers Squibb Company.

Farxiga is used in the treatment of diabetes, type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1427 5

Farxiga

Generic Name:
dapagliflozin
Imprint:
1427 5
Strength:
5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
SGLT-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb Company
National Drug Code (NDC):
00003-1427

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide